Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 2
1998 4
1999 3
2000 1
2001 3
2002 1
2003 5
2004 7
2005 8
2006 15
2007 14
2008 13
2009 20
2010 19
2011 29
2012 24
2013 21
2014 32
2015 48
2016 31
2017 36
2018 29
2019 36
2020 53
2021 52
2022 52
2023 63
2024 41

Text availability

Article attribute

Article type

Publication date

Search Results

625 results

Results by year

Filters applied: . Clear all
Page 1
RTS,S: the first malaria vaccine.
Zavala F. Zavala F. J Clin Invest. 2022 Jan 4;132(1):e156588. doi: 10.1172/JCI156588. J Clin Invest. 2022. PMID: 34981788 Free PMC article. Review. No abstract available.
RTS,S/AS01 malaria vaccine-proven safe and effective?
Björkman A, Benn CS, Aaby P, Schapira A. Björkman A, et al. Lancet Infect Dis. 2023 Aug;23(8):e318-e322. doi: 10.1016/S1473-3099(23)00126-3. Epub 2023 Apr 20. Lancet Infect Dis. 2023. PMID: 37086747 Review.
In October, 2021, WHO recommended that the RTS,S malaria vaccine, with its strong safety profile and high impact, be provided to children from age 5 months in regions with moderate to high Plasmodium falciparum malaria transmission. ...
In October, 2021, WHO recommended that the RTS,S malaria vaccine, with its strong safety profile and high impact, be provided …
The RTS,S malaria vaccine: Current impact and foundation for the future.
Beeson JG, Kurtovic L, Valim C, Asante KP, Boyle MJ, Mathanga D, Dobano C, Moncunill G. Beeson JG, et al. Sci Transl Med. 2022 Nov 16;14(671):eabo6646. doi: 10.1126/scitranslmed.abo6646. Epub 2022 Nov 16. Sci Transl Med. 2022. PMID: 36383682 Review.
The RTS,S vaccine has recently been recommended for implementation as a childhood vaccine in regions with moderate-to-high malaria transmission. ...
The RTS,S vaccine has recently been recommended for implementation as a childhood vaccine in regions with moderate-to-high mal …
RTS,S/AS01 vaccine (Mosquirix): an overview.
Laurens MB. Laurens MB. Hum Vaccin Immunother. 2020 Mar 3;16(3):480-489. doi: 10.1080/21645515.2019.1669415. Epub 2019 Oct 22. Hum Vaccin Immunother. 2020. PMID: 31545128 Free PMC article.
As this concerning trend calls for new tools to combat the disease, the RTS,S vaccine has arrived just in time. The vaccine was created in 1987 and began pilot implementation in endemic countries in 2019. ...
As this concerning trend calls for new tools to combat the disease, the RTS,S vaccine has arrived just in time. The vaccine wa …
RTS,S/AS01 malaria vaccine (Mosquirix()): a profile of its use.
Syed YY. Syed YY. Drugs Ther Perspect. 2022;38(9):373-381. doi: 10.1007/s40267-022-00937-3. Epub 2022 Sep 7. Drugs Ther Perspect. 2022. PMID: 36093265 Free PMC article. Review.
RTS,S/AS01 (Mosquirix()) is a vaccine against malaria caused by Plasmodium falciparum. ...In another phase 3 trial, RTS,S/AS01 was noninferior to seasonal malaria chemoprevention in children. ...
RTS,S/AS01 (Mosquirix()) is a vaccine against malaria caused by Plasmodium falciparum. ...In another phase 3 trial, RTS …
Mosquirix RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy.
Nadeem AY, Shehzad A, Islam SU, Al-Suhaimi EA, Lee YS. Nadeem AY, et al. Vaccines (Basel). 2022 Apr 30;10(5):713. doi: 10.3390/vaccines10050713. Vaccines (Basel). 2022. PMID: 35632469 Free PMC article. Review.
RTS, S is a vaccine for P. falciparum in which R specifies central repeat units, T the T-cell epitopes, and S indicates surface antigen. The RTS, S/AS01 malarial vaccine was synthesized and screened in several clinical trials between 2009 and 2014, inv …
RTS, S is a vaccine for P. falciparum in which R specifies central repeat units, T the T-cell epitopes, and S indicates surfac …
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.
RTS,S Clinical Trials Partnership. RTS,S Clinical Trials Partnership. Lancet. 2015 Jul 4;386(9988):31-45. doi: 10.1016/S0140-6736(15)60721-8. Epub 2015 Apr 23. Lancet. 2015. PMID: 25913272 Free PMC article. Clinical Trial.
BACKGROUND: The efficacy and safety of the RTS,S/AS01 candidate malaria vaccine during 18 months of follow-up have been published previously. ...The incidence of generalised convulsive seizures within 7 days of RTS,S/AS01 booster was 2.2 per 1000 doses …
BACKGROUND: The efficacy and safety of the RTS,S/AS01 candidate malaria vaccine during 18 months of follow-up have been publis …
RTS,S today and tomorrow's science.
Nkomba NN, Cairo C, Laufer MK. Nkomba NN, et al. Cell Host Microbe. 2022 May 11;30(5):604-606. doi: 10.1016/j.chom.2022.04.004. Cell Host Microbe. 2022. PMID: 35550662 Free PMC article.
The RTS,S malaria vaccine.
Casares S, Brumeanu TD, Richie TL. Casares S, et al. Vaccine. 2010 Jul 12;28(31):4880-94. doi: 10.1016/j.vaccine.2010.05.033. Epub 2010 May 27. Vaccine. 2010. PMID: 20553771 Review.
RTS,S is the most advanced candidate vaccine against human malaria. ...This review will focus on current knowledge about the protective efficacy of RTS,S and what we have learned regarding its impact on the human immune system....
RTS,S is the most advanced candidate vaccine against human malaria. ...This review will focus on current knowledge about the p …
RTS,S/AS02A for malaria.
Bojang KA. Bojang KA. Expert Rev Vaccines. 2006 Oct;5(5):611-5. doi: 10.1586/14760584.5.5.611. Expert Rev Vaccines. 2006. PMID: 17181435 Review.
In recent years, significant technological advances and an increase in funding for malaria vaccine research, including better public-private collaboration, have increased optimism that highly effective vaccines can be developed. RTS,S/AS02A is a novel pre-erythrocyt …
In recent years, significant technological advances and an increase in funding for malaria vaccine research, including better public-private …
625 results